Greehey Children's Cancer Research Institute
Category
October 24, 2020
Dr. Peter Houghton speaks to ecancer about the prospective validation of single mouse testing by the pediatric preclinical testing consortium; a study that was presented at ENA 2020 this year. Dr. Houghton initially explains the rationale behind this study and talks about how it was tested that using a single mouse for studying drug efficacy [...]September 11, 2019
Tiny, see-through fish might be the key to treating children with the rare muscle cancer, rhabdomyosarcoma. Local 13-year-old Kennedie Bailey, who just beat that cancer, saw the little zebrafish that may lead to a new treatment for other kids and prevent tumors from returning.
May 29, 2019
“Greg Aune, M.D. addresses attendees of the 2019 Annual (UT Health- San Antonio) President’s Luncheon “Why We Do What We Do”. Aune Lab
January 31, 2019
https://vimeo.com/314646779 “Moderator: Dr. Len Lichtenfeld, MD, Deputy Chief Medical Officer, American Cancer Society Mary Tankersley, Survivor, Rally Foundation Ambassador Dr. Greg Aune, MD, PhD, Pediatric Oncologist, Greehey Children’s Cancer Research Hospital Hon. Lee Satterfield, JD, Former Chief Judge, DC Superior Court Dr. Joshua Schiffman, MD, Professor of Pediatric Hematology/Oncology and Adjunct Professor of Oncological Sciences, Huntsman Cancer Center, University […]
December 14, 2018
https://www.youtube.com/watch?v=PCMFvlYPBfMDecember 12, 2018
UT Health San Antonio MD Anderson Cancer Center’s mission is to conquer cancer through research, prevention, and treatment—while offering world-class care close to home for patients in South Texas. How do ideas, collaboration, and dedication turn into hope for cancer patients? We’re how. You’re why. For more information about UT Health San Antonio, MD Anderson […]
September 18, 2018
CHILDHOOD CANCER HEARING LOSS AN EXTERNALLY-LED PATIENT-FOCUSED DRUG DEVELOPMENT WORKSHOP: CHEMOTHERAPY-INDUCED HEARING LOSS IN PEDIATRIC ONCOLOGY 3:25-3:35 Challenges in Clinical Trial Design in Chemotherapy-Induced Hearing Loss | Greg Aune, MD, PhD, Assistant Professor, UT Health San Antonio-Greehey Children’s Cancer Research Institute The half-day meeting follows the FDA model for externally-led PFDD meetings and will feature […]
September 13, 2018
The pediatric patient population with chemotherapy-induced hearing loss represents a segment of the cancer survivor community with a severe burden of disease with a great unmet medical need. An externally-led, FDA-approved Patient-Focused Drug Development (PFDD) meeting on September 13, 2018, near Washington, DC will explore these issues in-depth. The half-day meeting follows the FDA model […]